Persistent hiccups as an adverse event to FLAG-IDA regimen for leukemia.
Forghieri
Fabio
F
Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Azienda Ospedaliera Policlinico, Modena, Italy.
Maccaferri
Monica
M
Morselli
Monica
M
Potenza
Leonardo
L
Volzone
Francesco
F
Bandieri
Elena
E
Torelli
Giuseppe
G
Luppi
Mario
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects; D006606:Hiccup / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D015255:Idarubicin / Q000009:adverse effects; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012074:Remission Induction; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
D011994:Recombinant Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D014740:Vidarabine; D000069585:Filgrastim; D015255:Idarubicin